Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

NCT06561308 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Endometrioid Endometrial Cancer

Interventions

DRUG: Camrelizumab
DRUG: Carboplatin
DRUG: Paclitaxel
PROCEDURE: Surgery

Sponsor

Women's Hospital School Of Medicine Zhejiang University

Collaborators

Xiangya Hospital of Central South University
Tongji Hospital
Qilu Hospital of Shandong University
Anhui Provincial Cancer Hospital
Sichuan Cancer Hospital and Research Institute
Henan Provincial People's Hospital
Hunan Cancer Hospital
Zhejiang Cancer Hospital
First Affiliated Hospital of Wenzhou Medical University
Ningbo No. 1 Hospital
The First Affiliated Hospital of Zhengzhou University